Based on our previous findings that JLP is involved in LPA-stimulated activation of JNK [7, 8], we hypothesized that the aberrant expression of JLP could promote tumorigenesis or tumor progression in ovarian cancer. The gene discussed is SPAG9; the disease is ovarian carcinoma.